TITLE:
Common Complications in Late-Stage Bladder Cancer: A Five-Year Retrospective Study from a Nigerian Tertiary Hospital
AUTHORS:
Abraham T. Oladimeji, Olukayode A. Oseni, Kehinde O. Apata, Moses A. Ogunjimi, Arize M. E. Nwofor
KEYWORDS:
Bladder Cancer, Common Complications, Anemia, Renal Impairment
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.14 No.11,
November
19,
2026
ABSTRACT: Background: Bladder cancer is a common malignancy of the urinary tract and one of the leading causes of cancer-related illness and death worldwide. Even with advances in diagnosis and treatment, patients in many low- and middle-income countries still present with advanced disease and systemic complications. This is mostly because of late presentation and poor access to specialized care. Aim: This study recounts the demographic features, histological patterns, clinical presentation, and common complications of late-stage bladder cancer in patients treated at Federal Medical Center, Ebute Metta. Methods: We carried out a retrospective descriptive case series of all patients admitted with radiologically suspected bladder cancer between January 2021 and May 2026. Clinical records provided data on demographic features, presenting complaints, laboratory and radiological investigations, and histological diagnoses. Data were analyzed using descriptive statistics. Results: Eleven cases of radiologically suspected bladder cancer were included in the study: six males (54.5%) and five females (45.5%), with a male-to-female ratio of 1.2:1. The mean age was 55 ± 8.64 years (range: 42 - 68 years). Eight patients had histological diagnoses; five (62.5%) had urothelial carcinoma, and three (37.5%) had adenocarcinoma. The most common presenting complaint was painless visible hematuria. Anemia and renal impairment were the main complications, each affecting ten (90.9%) patients. The median hemoglobin concentration was 6.9 g/dL (range: 3.3 - 9.3 g/dL), median serum creatinine was 345 µmol/L (range: 56.5 - 1201 µmol/L), and median serum urea was 17.9 mmol/L (range: 2.5 - 64 mmol/L). Conclusion: Patients with bladder cancer in our environment usually present late. Severe anemia and renal impairment are the most common complications which can increase patient morbidity. Public awareness that promotes early diagnosis and prompt specialist referral are needed.